Insider · CIK 0001709772
Donald A Bergstrom
Files at RLAY (Relay Therapeutics, Inc.). First filing Oct 30, 2024, latest Sep 9, 2026.
Where the trades landed
Last year at the company this insider has traded most, with each buy and sell on the bar it happened.
RLAY: Relay Therapeutics, Inc.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 26Weak | Relay Therapeutics, Inc. | $162k 8,530 shares | -2% | +379% from low-8% from high | |
| 45Moderate | Relay Therapeutics, Inc. | $113k 30,770 shares | -5% | +85% from low-54% from high | |
| 45Moderate | Relay Therapeutics, Inc. | $95k 31,562 shares | -5% | +63% from low-60% from high | |
| 35Weak | Relay Therapeutics, Inc. | $2,800 986 shares | -0% | +5% from low-63% from high | |
| 55Moderate | Relay Therapeutics, Inc. | $362k 80,450 shares | -15% | +21% from low-43% from high | |
| 35Weak | Relay Therapeutics, Inc. | $2,878 657 shares | -0% | - | |
| 35Weak | Relay Therapeutics, Inc. | $16k 2,688 shares | -1% | - |
Transactions
Every row this insider has filed, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Sep 8, 2026 | RLAY Relay Therapeutics, Inc. | SOpen-market sale Common Stock10b5-1 | -8,530 | $18.97 | $162k | 399,130 | 33 d ago |
| Jul 28, 2025 | RLAY Relay Therapeutics, Inc. | SOpen-market sale Common Stock | -4,069 | $3.74 | $15k | 579,421 | Jul 30, 2025 |
| Jul 29, 2025 | RLAY Relay Therapeutics, Inc. | SOpen-market sale Common Stock | -26,701 | $3.68 | $98k | 552,720 | Jul 30, 2025 |
| Apr 28, 2025 | RLAY Relay Therapeutics, Inc. | SOpen-market sale Common Stock | -4,090 | $3.17 | $13k | 610,962 | Apr 30, 2025 |
| Apr 30, 2025 | RLAY Relay Therapeutics, Inc. | SOpen-market sale Common Stock | -27,472 | $3.00 | $82k | 583,490 | Apr 30, 2025 |
| Mar 27, 2025 | RLAY Relay Therapeutics, Inc. | SOpen-market sale Common Stock | -986 | $2.84 | $2,800 | 615,052 | Mar 31, 2025 |
| Jan 28, 2025 | RLAY Relay Therapeutics, Inc. | SOpen-market sale Common Stock | -3,220 | $4.63 | $15k | 516,868 | Jan 30, 2025 |
| Jan 28, 2025 | RLAY Relay Therapeutics, Inc. | AGrant or award Common Stock | +176,400 | $0.00 | $0 | 693,268 | Jan 30, 2025 |
| Jan 29, 2025 | RLAY Relay Therapeutics, Inc. | SOpen-market sale Common Stock | -46,407 | $4.55 | $211k | 646,861 | Jan 30, 2025 |
| Jan 30, 2025 | RLAY Relay Therapeutics, Inc. | SOpen-market sale Common Stock | -30,823 | $4.42 | $136k | 616,038 | Jan 30, 2025 |
| Jan 10, 2025 | RLAY Relay Therapeutics, Inc. | AGrant or award Stock Option (Right to Buy)derivative | +400,000 | $0.00 | $0 | 400,000 | Jan 14, 2025 |
| Dec 27, 2024 | RLAY Relay Therapeutics, Inc. | SOpen-market sale Common Stock | -657 | $4.38 | $2,878 | 520,088 | Dec 31, 2024 |
| Oct 28, 2024 | RLAY Relay Therapeutics, Inc. | SOpen-market sale Common Stock | -2,688 | $6.06 | $16k | 520,745 | Oct 30, 2024 |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.